Le Lézard
Classified in: Health, Science and technology
Subject: PER

Canopy Positions for Growth with Appointment of Susanne Clark as President


DANBURY, Conn., April 25, 2024 /PRNewswire/ -- Canopy Life Sciences ("Canopy"), a leading provider of clinical to commercial solutions to the life sciences industry, is delighted to announce the appointment of Susanne Clark as President. With over 25 years of experience in the life sciences industry, Susanne brings a wealth of knowledge and leadership to her new role.

Throughout her distinguished career, Susanne has cemented her reputation as a respected leader with a proven track record in shaping the strategic direction of global business development and operations. Recognized for her adeptness in assembling high-caliber teams and devising go-to-market strategies, she consistently achieves commercial success.

In her new role, Susanne will be entrusted with shaping Canopy's future, driving business growth, and ensuring success in a highly complex and competitive industry. Leveraging her deep industry knowledge, she will lead and execute the strategic vision for the organization, collaborating with division leaders, overseeing a coordinated sales and business development effort, and ensuring the delivery of high-quality services and products to clients.

Prior to joining Canopy, Susanne served as President and Chief Strategy Officer of the Integrated Medical Communications Capabilities and Solutions division at Envision Pharma Group (EPG) for 18 years. Her tenure and professional achievements played a pivotal role in the growth of EPG.

"I am excited to welcome Susanne to the Canopy team," said Joe Walsh, CEO of Canopy. "This new position is critical to the fulfillment of our mission, business expansion, and serving the needs of our clients. Susanne's experience and proven leadership will be instrumental in driving our success in the years to come."

Susanne Clark expressed her enthusiasm about joining Canopy. "I am thrilled and honored to be a part of the Canopy team at a time of exciting growth and advancement," said Susanne Clark. "I'm eager to enhance Canopy's value through excellence in service and the integration of new products and technologies, while maintaining our steadfast commitment to continuous innovation."

About Canopy Life Sciences:

Canopy Life Sciences provides clinical to commercial solutions to over 225 biotechnology, pharmaceutical, and medical device companies. The company offers solutions in the areas of Regulatory Affairs, Regulatory Operations, MLR, Content Innovation, Medical Affairs, Technology, and Global Recruiting.

Here to get your science there.

More information can be found here: www.hellocanopy.com

For media inquiries, please contact:
Linda Paternostro
Canopy Life Sciences
Direct +1860-799-7510 Ext: 131
[email protected]

SOURCE Canopy Life Sciences


These press releases may also interest you

at 02:34
Elbit Systems Ltd.  ("Elbit Systems" or the "Company") announced today that it was awarded an initial contract of approximately $37 million to supply Iron Fist Active Protection Systems (APS) to General Dynamics Ordnance and Tactical Systems...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
U.S.-based tech startup Iozera, in collaboration with the Government of Morocco, announces an initiative set to transform the AI industry. Iozera has announced the signing of a Memorandum of Understanding (MOU) for the establishment of a pioneering...

4 mai 2024
OKX, a leading Web3 technology company, has issued updates for May 3, 2024. OKX today announced that its Web3 Wallet is now...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
With a remarkable achievement of 81.556 billion yuan in operating revenue, marking an 11.74% increase from the previous year, and a net profit attributable to shareholders of 7.039 billion yuan, soaring by 27.21%, JA Solar hit historic highs in both...



News published on and distributed by: